• 1
    Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994; 343: 11991206.
  • 2
    Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995; 92: 43924396.
  • 3
    Chinje EC, Stratford IJ. Role of nitric oxide in growth of solid tumors: a balancing act. Essays Biochem. 1997; 32: 6172.
  • 4
    Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998; 58: 334341.
  • 5
    Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer. 1998; 82: 18971903.
  • 6
    Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer. 1998; 78: 534541.
  • 7
    Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst. 1998; 90: 587596.
  • 8
    Tschugguel W, Pustelnik T, Lass H, et al. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer. 1999; 79: 16091612.
  • 9
    Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994; 54: 13521354.
  • 10
    Zeillinger R, Tantscher E, Schneeberger C, et al. Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res Treat. 1996; 40: 205207.
  • 11
    Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer. 1995; 72: 4144.
  • 12
    von Minckwitz G, Kaufmann M, Schmid H, Goerttler K, Bastert G. Epidermal growth factor receptor and s-phase fraction as prognosticator combination in node negative primary breast cancer. Breast. 1993; 2: 229233.
  • 13
    Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984; 32: 219229.
  • 14
    Vanin AF, Kleschyov AL. EPR detection and biological implications of nitrosyl non-heme iron complexes. In: LukiewiczSJ, ZweierJL, editors. Nitric oxide in transplant rejection and anti-tumor defense. London: Kluwer, 1998: 4982.
  • 15
    Kleschyov AL, Mollnau H, Oelze M, et al. Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. Biochem Biophys Res Commun. 2000; 275: 672677.
  • 16
    Tschugguel W, Knogler W, Czerwenka K, et al. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br J Cancer. 1996; 74: 14231426.
  • 17
    Feuerhake F, Unterberger P, Hofter EA. Cell turnover in apocrine metaplasia of the human mammary gland epithelium: apoptosis, proliferation, and immunohistochemical detection of Bcl-2, Bax, EGFR, and c-erbB2 gene products. Acta Histochem. 2001; 103: 5365.
  • 18
    Jones C, Damiani S, Wells D, Chaggar R, Kakhani SR, Eusebi V. Molecular cytogenic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol. 2001; 158: 207214.
  • 19
    Martin JHJ, Begum S, Alalami O, Harrison A, Scott KWM. Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumor Biol. 2000; 21: 9097.
  • 20
    Vakkala M, Paakko P, Soini Y. c-NOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int J Oncol. 2000; 17: 667671.
  • 21
    Reveneau S, Arnould L, Jolimoy G, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest. 1999; 79: 12151225.
  • 22
    Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997; 273: 119126.
  • 23
    MacRitchie AN, Jun SS, Chen Z, et al. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circul Res. 1997; 81: 355362.
  • 24
    Mokbel K. The twenty-third annual San Antonio Breast Cancer Symposium. Curr Med Res Opin. 2001; 16: 276284.
  • 25
    Clark GM, Osborne CK, McGuire WL. Correlations between estrogen receptor, progesterone receptor, and patients characteristics in human breast cancer. J Clin Oncol. 1984; 2: 11021110.
  • 26
    Chhatwal VJ, Ngoi SS, Chan ST, Chia YW, Moochhala SM. Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis. 1994; 15: 20812085.